A
Altimmune, Inc. (ALT)
NGM – Real Time Price. Currency in USD
3.02
-0.18 (-5.63%)
At close: Mar 27, 2026, 4:00 PM EDT
3.07
+0.05 (1.66%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
3.02
-0.18 (-5.63%)
At close: Mar 27, 2026, 4:00 PM EDT
3.07
+0.05 (1.66%)
After-hours: Mar 27, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 18.54 | 6.05 | 10 | |
| Quick ratio | 18.54 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.13 | 1.04 | 8.0 | |
| Interest coverage | -32.98 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | -68K | 426K | 20K | 41K | 41K |
| Gross Profit | -568K | -51K | -218K | -71K | -71K |
| Operating Income | -88M | -84M | -103M | -94M | -94M |
| Net Income | -85M | -88M | -95M | -88M | -88M |
| EBITDA | -87M | -83M | -103M | -94M | -94M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -80 | 7.66 | 3.5 |
| Next quarter | -80 | 7.34 | 3.0 |
| Current year | -86.34 | -10.02 | 1.0 |
| Next year | -100 | -7.21 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 420 | -43.87 | -28.56 | -60.96 | 3.3 |
| Y/Y | 420 | -18.01 | 18.18 | -4.84 | 5.3 |
| 3y average | 245.39 | -1.5 | 17.65 | -3.6 | 5.3 |
| 5y average | 117.71 | -17.94 | 10.58 | -28.25 | 4.8 |
| Weighted average score | 4.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $43.8M significantly exceed its total debt $35.7M, ensuring strong financial flexibility
Total current assets $278.0M exceed Total current liabilities $15.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-33.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$19.2M limits the company's ability to reinvest or pay down debt